Sébastien Gibot

ORCID: 0000-0001-6067-4662
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammation biomarkers and pathways
  • Sepsis Diagnosis and Treatment
  • Intensive Care Unit Cognitive Disorders
  • Respiratory Support and Mechanisms
  • Nosocomial Infections in ICU
  • Apelin-related biomedical research
  • COVID-19 Clinical Research Studies
  • Immune Response and Inflammation
  • Cardiac Arrest and Resuscitation
  • Pneumonia and Respiratory Infections
  • Neonatal and Maternal Infections
  • Public Health and Nutrition
  • Long-Term Effects of COVID-19
  • Methodologies in Health Research and Practice
  • SARS-CoV-2 and COVID-19 Research
  • Kawasaki Disease and Coronary Complications
  • Hemodynamic Monitoring and Therapy
  • Mesenchymal stem cell research
  • Sports and Physical Education Research
  • Vitamin C and Antioxidants Research
  • Advanced Glycation End Products research
  • Heart Failure Treatment and Management
  • Family and Patient Care in Intensive Care Units
  • Renal function and acid-base balance
  • Antibiotic Resistance in Bacteria

Centre Hospitalier Régional et Universitaire de Nancy
2015-2024

Université de Lorraine
2014-2024

Imation (United States)
2006-2024

Assistance Publique – Hôpitaux de Paris
2004-2024

National and Kapodistrian University of Athens
2024

Evangelismos Hospital
2024

Hôpital Saint-Louis
2024

Inserm
2012-2023

Université de Lille
2023

Défaillance Cardiovasculaire Aiguë et Chronique
2014-2021

The diagnosis and treatment of bacterial pneumonia in patients who are receiving mechanical ventilation remain a difficult challenge. triggering receptor expressed on myeloid cells (TREM-1) is member the immunoglobulin superfamily, its expression phagocytes specifically up-regulated by microbial products. presence soluble TREM-1 (sTREM-1) bronchoalveolar-lavage fluid from may be an indicator pneumonia.

10.1056/nejmoa031544 article EN New England Journal of Medicine 2004-01-29

Background: Previous experimental studies have suggested that the triggering receptor expressed on myeloid cells-1 (TREM-1) is specifically upregulated in presence of microbial products. Objective: To evaluate diagnostic value plasma levels soluble form TREM-1 patients admitted with clinical suspicion infection. Design: Prospective, noninterventional study conducted between July and September 2003. Setting: Medical adult intensive care unit at a university hospital France. Participants: 76...

10.7326/0003-4819-141-1-200407060-00009 article EN Annals of Internal Medicine 2004-07-06
Florence Ader Maude Bouscambert‐Duchamp Maya Hites Nathan Peiffer‐Smadja Julien Poissy and 95 more Drifa Belhadi Alpha Diallo Minh Patrick Lê Gilles Peytavin Thérèse Staub Richard Greil Jérémie Guedj José Artur Paiva Dominique Costagliola Yazdan Yazdanpanah Charles Burdet France Mentré Alexander Egle Richard Greil Michael Joannidis Bernd Lamprecht Antoine Altdorfer Leïla Belkhir Vincent Fraipont Maya Hites Gil Verschelden Jérôme Aboab Florence Ader Hafid Aït-Oufella Claire Andréjak Pascal Andreu Laurent Argaud Firouzé Bani‐Sadr François Bénézit Mathieu Blot Élisabeth Botelho-Nevers Lila Bouadma Olivier Bouchaud David Bougon Kévin Bouiller Fanny Vardon‐Bounes D. Boutoille Alexandre Boyer Cédric Bruel André Cabie Emmanuel Canet Charles Cazanave Cyrille Chabartier Catherine Chirouze Raphaël Clère-Jehl Johan Courjon Flora Crockett François Danion Agathe Delbove Jean Dellamonica Félix Djossou C Dubost Alexandre Duvignaud Olivier Épaulard Loïc Epelboin Murielle Fartoukh Karine Faure Emmanuel Faure Tristan Ferry C. Ficko Samy Figueiredo Benjamin Gaborit Rostane Gaci Amandine Gagneux‐Brunon Sébastien Gallien Denis Garot Guillaume Géri Sébastien Gibot François Goehringer Marie Gousseff Didier Gruson Yves Hansmann O. Hinschberger Stéphane Jauréguiberry Vanessa Jean-Michel Solen Kernéis Antoine Kimmoun Kada Klouche Marie Lachâtre Karine Lacombe Fabrice Laine Jean‐Philippe Lanoix Odile Launay Bruno Laviolle Vincent Le Moing Jérôme Le Pavec Yves Le Tulzo Paul Le Turnier David Lebeaux Benjamin Lefèvre Sylvie Leroy François‐Xavier Lescure Henry Lessire Benjamin Leveau Paul Loubet

10.1016/s1473-3099(21)00485-0 article EN publisher-specific-oa The Lancet Infectious Diseases 2021-09-14

Although the outcome of sepsis benefits from prompt administration appropriate antibiotics on correct diagnosis, assessment infection in critically ill patients is often a challenge for clinicians. In this setting, simple biomarkers, especially when used combination, could prove useful.To determine usefulness combination biomarkers to diagnose sepsis.Three hundred consecutive were enrolled construct biologic score that was next validated an independent prospective cohort 79 another...

10.1164/rccm.201201-0037oc article EN American Journal of Respiratory and Critical Care Medicine 2012-04-27

Whether the antiinflammatory and immunomodulatory effects of glucocorticoids may decrease mortality among patients with severe community-acquired pneumonia is unclear.In this phase 3, multicenter, double-blind, randomized, controlled trial, we assigned adults who had been admitted to intensive care unit (ICU) for receive intravenous hydrocortisone (200 mg daily either 4 or 7 days as determined by clinical improvement, followed tapering a total 8 14 days) placebo. All received standard...

10.1056/nejmoa2215145 article EN New England Journal of Medicine 2023-03-21
Peter Pickkers Derek C. Angus Kristie Bass Rinaldo Bellomo Erik van den Berg and 95 more Juliane Bernholz Morten H. Bestle Kent Doi Chistopher J. Doig Ricard Ferrer Bruno François Henrik Gammelager U. G. Pedersen Eric A. J. Hoste Susanne Iversen Michael Joannidis John A. Kellum Kathleen D. Liu Melanie Meersch Ravindra L. Mehta Scott J. Millington Patrick Murray Alistair Nichol Marlies Ostermann Ville Pettilä Christoffer Sølling Matthias Winkel Paul J. Young Alexander Zarbock Angus Carter D Friès Philip Eller Ludovic Gérard Nicolas DeSchryver Elisabeth Diltoer Vincent Huberlant Isabelle Michaux Patrick M. Honorè Tom Fivez Christopher J. Doig Gordon Wood J. Gordon Boyd Alexis F. Turgeon Maj K. Kamper Thomas Strøm Sussanne Iversen Hendrik Gammelager Bodil Steen Rasmussen Christoffer Sølling Morten Hyllander Mæller Thorbjoern Groefte Nilanjan Dey Ulf Gøttrup Pedersen Mila Valkonen Panu Uusalo Ville Jalkanen Ferhat Meziani Jermie Lemarie Gaëtan Plantefève Konstantimos Bachoumas Jean Louis Dufour Anne-Laure Fedou Pierre Asfar Xavier Monnet Christophe Vinsonneau Sébastien Gibot Christophe Guitton Jean‐Pierre Quenot Grégoire Müller Jean Yves Lefrant Emmanuelle Mercier Alexandre Mebazaa Andreas Kortgen Sebastian Fichtner Stefan Kluge Gernot Marx Ignatio Martin-Loeches Bairbre McNicolas Hidenobu Kamohara Masahiro Harada Takuo Nakagami Shingo Adachi Kohei Ota Ryo Furuya Ayumu Tsuruoka Yasuaki Mizushima Satoki Inoue Pieter R. Tuinman F Wim Roozendaal Bert Beishuizen Oscar Hoiting Tom Dormans Arthur R. H. van Zanten Paul J. Young Anthony P. Williams Colin McArthur Paweł Twardowski Shay McGuinness Ricard Ferrer Carol Lorencio Cardenas

Ilofotase alfa is a human recombinant alkaline phosphatase with reno-protective effects that showed improved survival and reduced Major Adverse Kidney Events by 90 days (MAKE90) in sepsis-associated acute kidney injury (SA-AKI) patients. REVIVAL, was phase-3 trial conducted to confirm its efficacy safety. In this international double-blinded randomized-controlled trial, SA-AKI patients were enrolled < 72 h on vasopressor 24 of AKI. The primary endpoint 28-day all-cause mortality. main...

10.1007/s00134-023-07271-w article EN cc-by-nc Intensive Care Medicine 2024-01-01

The triggering receptor expressed on myeloid cells (TREM)-1 is a recently discovered the surface of neutrophils and subset monocytes. Engagement TREM-1 has been reported to trigger synthesis proinflammatory cytokines in presence microbial products. Previously, we have identified soluble form (sTREM-1) observed significant levels serum samples from septic shock patients but not controls. Here, investigated its putative role modulation inflammation during sepsis. We that sTREM-1 was secreted...

10.1084/jem.20040708 article EN The Journal of Experimental Medicine 2004-11-22

Objective: To describe the course of plasma sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin (PCT), and C-reactive protein (CRP) concentrations during sepsis their clinical informative value in predicting outcome. Design: Prospective, noninterventional study. Setting: Medical adult intensive care unit at a university hospital France. Patients: Sixty-three critically ill patients with sepsis, severe or septic shock. Interventions: None. Measurements Main...

10.1097/01.ccm.0000159089.16462.4a article EN Critical Care Medicine 2005-04-01

During septic shock, muscle produces lactate by way of an exaggerated NaK-adenosine triphosphatase (ATPase)-stimulated aerobic glycolysis associated with epinephrine stimulation possibly through beta2 adrenoreceptor involvement. It therefore seems logical that a proportion hyperlactatemia in low cardiac output states would be also related to this mechanism. Thus, low-flow and normal-to-high-flow models we investigate (1) whether (2) production is linked adrenergic Na+K+-ATPase. We locally...

10.1097/shk.0b013e318167378f article EN Shock 2008-09-17

Metformin-associated lactic acidosis (MALA) is a classic side effect of metformin and known to be severe disease with high mortality rate. The treatment MALA dialysis controversial the subject many case reports in literature. We aimed assess prevalence 16-bed, university-affiliated, intensive care unit (ICU), on patient outcome.Over five-year period, we retrospectively identified all patients who were either admitted ICU as usual medication, or attempted suicide by ingestion. Within this...

10.1186/cc7137 article EN cc-by Critical Care 2008-11-26

Rationale: Optimal outcome after myocardial infarction (MI) depends on a coordinated healing response in which both debris removal and repair of the extracellular matrix play major role. However, adverse remodeling excessive inflammation can promote heart failure, positioning leucocytes as central protagonists potential therapeutic targets tissue wound MI. Objective: In this study, we examined role triggering receptor expressed myeloid cells-1(TREM-1) orchestrating inflammatory that follows...

10.1161/circresaha.116.305628 article EN Circulation Research 2015-04-04

Primary objective was to identify leukocyte subsets that could predict the early evolution of sepsis at 48 hours (i.e., deterioration or stability/improvement). Secondary objectives were evaluate prognostic value on mortality and immunosuppressive properties immature granulocytes.Twenty-three peripheral blood analyzed using a new-generation 10-color flow cytometry. T-cell killing activity granulocytes explored sorting method specifically developed.ICUs emergency departments.All patients...

10.1097/ccm.0000000000000344 article EN Critical Care Medicine 2014-06-18

Abstract During sepsis, neutrophil activation induces endothelial cell (EC) dysfunction partly through extracellular trap (NET) release. The triggering receptor expressed on myeloid cell-1 (TREM-1) is an orphan immune that amplifies the inflammatory response mediated by Toll-like receptor-4 (TLR4) engagement. Although key role of TLR4 signaling in NETosis known, TREM-1 this process has not yet been investigated. Here, we report potentiates NET release human and murine neutrophils a component...

10.1038/s41423-020-00591-7 article EN cc-by Cellular and Molecular Immunology 2021-01-08
Jean Chastre Bruno François Marc Bourgeois Apostolos Komnos Ricard Ferrer and 95 more Galia Rahav Nicolas De Schryver Alain Lepape İftihar Köksal Charles‐Édouard Luyt Miguel Sánchez García Antoní Torres Philippe Eggimann Despoina Koulenti Thomas L Holland Omar Ali Kathryn Shoemaker Pin Ren Julien Sauser Alexey Ruzin David E. Tabor Ahmad Akhgar Yuling Wu Yu Jiang Antonio DiGiandomenico Susan Colbert Drieke Vandamme Frank E. J. Coenjaerts Surbhi Malhotra‐Kumar Leen Timbermont Antonio Oliver Olivier Barraud Terramika Bellamy Marc J. M. Bonten Herman Goossens Colin Reisner Mark T. Esser Hasan S. Jafri Michael Joannidis Walter Klimscha Elisabeth De Waele Jacques Devriendt Vincent Huberlant Pieter Depuydt Sam Van Boxstael Mladen Perić Jasminka Kopić Michal Hanauer Tomas Hruby Vladimír Šrámek Petr Svoboda Tomáš Vymazal Martin Nováček Djillali Annane Jean‐Paul Mira Bertrand Souweine Pierre‐François Dequin Ferhat Meziani François Stéphan Saadalla Nseir Sébastien Gibot Carole Schwebel Gaëtan Plantefève Jean‐Luc Diehl Christian Richard Christian Lamer Kada Klouche Samir Jaber Epaminondas Zakynthinos Georgios Filntisis Spyros Zakynthinos Antonia Koutsoukou Georgios Saroglou Charikleia Nikolaou Glykeria Vlachogianni Ioannis Pnevmatikos Konstantinos Mandragos Ildikó Krémer Zsolt Dezso Rozgonyi Zsuzsa Marjanek Ignacio Martín‐Loeches Pierre Singer Vernon van Heerden Yehuda Carmeli Pedro Póvoa Antonio Alvarez Seoane Pedro Henrique de Moura Filipe Gonzalez Paula Ramírez Antonio Torres Martí Ricard Ferrer Lorena Oteiza D. Escudero Enrique Piacentini Paula Vera Luis Tamayo Miguel Angel Gonzalez Gallego B. Suberviola Cañas Iglesias Figueira Rafael Camino León

Abstract Background Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (PA) in hospitalised patients is associated with high mortality. The effectiveness of the bivalent, bispecific mAb MEDI3902 (gremubamab) preventing PA nosocomial was assessed PA-colonised mechanically ventilated subjects. Methods EVADE (NCT02696902) a phase 2, randomised, parallel-group, double-blind, placebo-controlled study Europe, Turkey, Israel, and USA. Subjects ≥ 18 years old, ventilated, tracheally...

10.1186/s13054-022-04204-9 article EN cc-by Critical Care 2022-11-15

Objective Genetic differences in immune responses may affect susceptibility to and outcome of septic shock. CD14 seems be an important part the innate system, initiating antimicrobial response. We evaluated frequency a recently discovered promoter gene polymorphism (C T transition at base pair −159) among patients with shock compared those control group. Design Multiple-center study. Setting Hospital research department. Patients Ninety consecutive white were included. The group consisted...

10.1097/00003246-200205000-00003 article EN Critical Care Medicine 2002-05-01

Abstract Triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently identified molecule involved in the amplification of inflammation. To determine regulation TREM-1, we studied TREM-1 expression and soluble plasma levels upon i.v. LPS challenge healthy humans vivo vitro. Granulocyte was high at baseline immediately down-regulated exposure along with an increase TREM-1. Monocytes displayed gradual up-regulation In vitro studies extended these findings to highly purified...

10.4049/jimmunol.173.12.7131 article EN The Journal of Immunology 2004-12-15
Coming Soon ...